Cronos Group (NASDAQ:CRON) Hits New 52-Week Low – Here’s What Happened

Cronos Group Inc. (NASDAQ:CRON)’s share price hit a new 52-week low during mid-day trading on Monday . The company traded as low as $1.78 and last traded at $1.82, with a volume of 2332484 shares changing hands. The stock had previously closed at $1.82.

Cronos Group Price Performance

The firm has a market cap of $700.03 million, a P/E ratio of -14.08, a PEG ratio of 1.74 and a beta of 0.89. The firm’s 50-day moving average price is $1.93 and its 200 day moving average price is $2.04.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Thompson Davis & CO. Inc. bought a new stake in shares of Cronos Group in the 4th quarter valued at approximately $29,000. Tower Research Capital LLC TRC boosted its holdings in Cronos Group by 140.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company’s stock worth $28,000 after purchasing an additional 8,019 shares during the period. SBI Securities Co. Ltd. bought a new stake in Cronos Group during the fourth quarter valued at $30,000. Jones Financial Companies Lllp raised its holdings in shares of Cronos Group by 64.5% during the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company’s stock worth $34,000 after purchasing an additional 6,520 shares during the period. Finally, Quantbot Technologies LP bought a new position in shares of Cronos Group in the 3rd quarter worth about $37,000. Institutional investors own 8.71% of the company’s stock.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.